MENU

BBOT

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

BridgeBio Oncology Therapeutics (BBOT) Ownership - Who owns BridgeBio Oncology Therapeutics?

BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Details

Group

Domestic Stock Funds

Category

Biotechnology

Capitalization

630.44M

P/E Ratio

N/A

Total Cash

252.28M

Projected Growth

N/A

Total Debt

2.64M

Revenue

N/A

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash/Share

3.15

Total Debt/Equity

N/A

Revenue/Share

null USD as % of share price

View a ticker or compare two or three

VS

VS

BBOT

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for BBOT

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Details